| Literature DB >> 35447785 |
Emily A W Nadeau1, Melise C Lecheta1, John J Obrycki1, Nicholas M Teets1.
Abstract
Diapause is an alternate development program that synchronizes an insect's life cycle with seasonally abundant resources and ensures survival in unfavorable conditions. The physiological basis of diapause has been well characterized, but the molecular mechanisms regulating it are still being elucidated. Here, we present a de novo transcriptome and quantify transcript expression during diapause in the convergent lady beetle Hippodamia convergens. H. convergens is used as an augmentative biocontrol agent, and adult females undergo reproductive diapause that is regulated by photoperiod. We sampled females at three stages (early, mid, and late diapause) and compared transcript expression to non-diapausing individuals. Based on principle component analysis, the transcriptomes of diapausing beetles were distinct from non-diapausing beetles, and the three diapausing points tended to cluster together. However, there were still classes of transcripts that differed in expression across distinct phases of diapause. In general, transcripts involved in muscle function and flight were upregulated during diapause, likely to support dispersal flights that occur during diapause, while transcripts involved in ovarian development were downregulated. This information could be used to improve biological control by manipulating diapause. Additionally, our data contribute to a growing understanding of the genetic regulation of diapause across diverse insects.Entities:
Keywords: Coleoptera; RNA-Seq; biological control; reproductive diapause; transcriptomics
Year: 2022 PMID: 35447785 PMCID: PMC9026804 DOI: 10.3390/insects13040343
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 3.139
De novo assembly and annotation statistics. 636 million paired-end reads were assembled into 238,614 contigs with Trinity. BUSCOs were compared with all other available Arthropod transcriptomes. BLAST, GO, KEGG, and Pfam domains were annotated using Trinotate.
| Assembly Statistics | Annotation Statistics | ||
|---|---|---|---|
| Assembly length (bp) | 199,457,684 | Complete BUSCOs | 96.2% |
| Contigs | 238,614 | Contigs with BLAST hit | 31.8% |
| N50 | 1442 | Contigs with GO description | 29.4% |
| Range of contig lengths | 201–17,262 | Contigs with KEGG IDs | 23.9% |
| Number of reads | 636,203,876 | Contigs with Pfam domain(s) | 21.9% |
Figure 1Principle Component Analysis (PCA) score plots of samples. This PCA was used to determine the relationship between transcript expression profiles from various stages of diapause. One of the mid-diapause samples was removed from the dataset prior to this analysis due to technical problems with the sample, so there are only three replicates for this group. One LD sample clustered with the ND samples, and that female had already broken diapause and started ovipositing at the time of sample collection. Thus, this sample was removed from further analyses. ED = early diapause, LD = late diapause, MD = mid-diapause, ND = non-diapause.
Figure 2MA plots showing the number of differentially expressed transcripts between each diapausing stage and non-diapause beetles. For each comparison ((a): ED vs. ND; (b): MD vs. ND; (c): LD vs. ND), transcripts with FDR < 0.05 are shown in blue. In each panel the total number of up- and downregulated transcripts are indicated. For the full lists of differentially expressed transcripts, see Table S1. ED = early diapause, MD = mid-diapause, LD = late diapause, ND = non-diapause.
Summary of the GO biological processes that are involved in ED. The table shows GO terms that are significantly enriched among transcripts that are either up- or downregulated during ED relative to ND. The top five up and down enriched GO terms for this comparison are shown. Redundant GO terms were removed using semantic clustering with REVIGO. GO terms that are enriched in the MD vs. ED comparison are shown in Table 3, and a complete list of enriched GO terms can be found in Supplementary Table S2.
| Comparison | GO ID | GO Term | Unadjusted | Adjusted |
|---|---|---|---|---|
| Upregulated Relative to ND | GO:0045214 | Sarcomere organization | 1.49 × 10−14 | 1.08 × 10−10 |
| GO:0030239 | Myofibril assembly | 2.54 × 10−9 | 6.16 × 10−6 | |
| GO:0007517 | Muscle organ development | 1.91 × 10−8 | 3.97 × 10−5 | |
| GO:0030241 | Skeletal muscle myosin thick filament assembly | 2.19 × 10−8 | 3.98 × 10−5 | |
| GO:0006936 | Muscle contraction | 2.95 × 10−8 | 4.77 × 10−5 | |
| Downregulated Relative to ND | GO:0007049 | Cell cycle | 3.54 × 10−13 | 2.58 × 10−9 |
| GO:0051301 | Cell division | 1.73 × 10−12 | 4.20 × 10−9 | |
| GO:0006417 | Regulation of translation | 4.59 × 10−8 | 4.45 × 10−5 | |
| GO:0005980 | Glycogen catabolic process | 1.39 × 10−7 | 1.12 × 10−4 | |
| GO:0005978 | Glycogen biosynthetic process | 2.25 × 10−7 | 1.72 × 10−4 |
Summary of the top five (when available) KEGG pathways involved in ED. The table shows KEGG pathways that were up- and downregulated relative to ED. Enriched KEGG pathways relative to ND were identified with the GAGE and Pathview packages in R. Terms were sorted by the Benjamini-Hochberg adjusted p-value. KEGG pathways differentially expressed relative to MD are shown in Table 5, and a complete list of up- and downregulated KEGG terms can be found in Supplementary Table S3.
| Comparison | KO ID | KEGG Term | Adjusted |
|---|---|---|---|
| Upregulated Relative to ND | ko00190 | Oxidative phosphorylation | 1.23 × 10−7 |
| ko04260 | Cardiac muscle contraction | 1.66 × 10−7 | |
| ko04723 | Retrograde endocannabinoid signaling | 7.58 × 10−5 | |
| ko01120 | Microbial metabolism in diverse environments | 9.00 × 10−5 | |
| ko04022 | cGMP-PKG signaling pathway | 2.18 × 10−3 | |
| Downregulated Relative to ND | ko03013 | RNA transport | 2.13 × 10−7 |
| ko04110 | Cell cycle | 2.13 × 10−7 | |
| ko03030 | DNA replication | 1.02 × 10−6 | |
| ko04120 | Ubiquitin mediated proteolysis | 2.95 × 10−5 | |
| ko03018 | RNA degradation | 6.92 × 10−4 |
Summary of the GO biological processes that are involved in MD. The table shows GO terms that are significantly enriched in differentially expressed transcripts from the MD vs. ND, MD vs. ED, and MD vs. LD comparisons. The top five enriched GO terms among up- and downregulated transcripts for these comparisons are shown. Redundant GO terms were removed using semantic clustering with REVIGO. A complete list of enriched GO terms can be found in Supplementary Table S2.
| Comparison | GO ID | GO Term | Unadjusted | Adjusted |
|---|---|---|---|---|
| Upregulated Relative to ND | GO:0045214 | Sarcomere organization | 5.10 × 10−14 | 2.47 × 10−10 |
| GO:0030241 | Skeletal muscle myosin thick filament assembly | 4.21 × 10−10 | 1.23 × 10−6 | |
| GO:0007517 | Muscle organ development | 1.87 × 10−9 | 4.54 × 10−6 | |
| GO:0060537 | Muscle tissue development | 8.28 × 10−9 | 1.42 × 10−5 | |
| GO:0015866 | ADP transport | 8.75 × 10−9 | 1.42 × 10−5 | |
| Downregulated Relative to ND | GO:0043161 | Proteasome-mediated ubiquitin-dependent protein catabolic process | 3.60 × 10−7 | 1.05 × 10−3 |
| GO:0051301 | Cell division | 3.18 × 10−6 | 6.61 × 10−3 | |
| GO:0010498 | Proteasomal protein catabolic process | 4.20 × 10−6 | 6.77 × 10−3 | |
| GO:0008103 | Oocyte microtubule cytoskelton polarization | 6.66 × 10−6 | 6.77 × 10−3 | |
| GO:0007052 | Mitotic spindle organization | 6.95 × 10−6 | 6.77 × 10−3 | |
| Upregulated Relative to ED | GO:0000272 | Polysaccharide catabolic process | 1.51 × 10−7 | 7.33 × 10−4 |
| GO:0006032 | Chitin catabolic process | 1.65 × 10−6 | 2.67 × 10−3 | |
| GO:0006869 | Lipid transport | 5.46 × 10−6 | 7.23 × 10−3 | |
| GO:0015986 | ATP synthesis coupled proton transport | 9.58 × 10−6 | 1.09 × 10−2 | |
| GO:0007594 | Puparial adhesion | 9.78 × 10−6 | 1.09 × 10−2 | |
| Downregulated Relative to ED | None | |||
| Upregulated Relative to LD | None | |||
| Downregulated Relative to LD | None |
Summary of the top five (when available) KEGG pathways involved in MD. The table shows KEGG pathways that were up- or downregulated relative to ND, ED, and LD. Enriched KEGG pathways were identified with the GAGE and Pathview packages in R. Terms were sorted by the Benjamini-Hochberg adjusted p-value. A complete list of up- and downregulated KEGG terms can be found in Supplementary Table S3.
| Comparison | KO ID | KEGG Term | Adjusted |
|---|---|---|---|
| Upregulated Relative to ND | ko04260 | Cardiac muscle contraction | 4.30 × 10−3 |
| ko04022 | cGMP-PKG signaling pathway | 4.30 × 10−3 | |
| ko04020 | Calcium signaling pathway | 1.87 × 10−2 | |
| ko04723 | Retrograde endocannabinoid signaling | 3.40 × 10−2 | |
| ko04745 | Phototransduction—fly | 5.20 × 10−2 | |
| Downregulated Relative to ND | ko04110 | Cell cycle | 4.63 × 10−2 |
| ko04120 | Ubiquitin mediated proteolysis | 4.63 × 10−2 | |
| ko03440 | Homologous recombination | 5.15 × 10−2 | |
| ko03030 | DNA replication | 5.15 × 10−2 | |
| ko03013 | RNA transport | 5.15 × 10−2 | |
| Upregulated Relative to ED | ko01110 | Biosynthesis of secondary metabolites | 6.47 × 10−6 |
| ko00500 | Starch and sucrose metabolism | 2.95 × 10−4 | |
| ko00190 | Oxidative phosphorylation | 6.35 × 10−4 | |
| ko02010 | ABC transporters | 2.68 × 10−3 | |
| ko00052 | Galactose metabolism | 2.85 × 10−3 | |
| Downregulated Relative to ED | ko03010 | Ribosome | 1.04 × 10−3 |
| ko03013 | RNA transport | 8.02 × 10−2 | |
| ko04110 | Cell cycle | 8.02 × 10−2 | |
| Upregulated Relative to LD | ko00190 | Oxidative phosphorylation | 8.98 × 10−3 |
| Downregulated Relative to LD | None |
Summary of the GO biological processes that are involved in LD. The table shows GO terms that are significantly enriched among transcripts that are either up- or downregulated during LD relative to ND. The top five up and down enriched GO terms for this comparison are shown. Redundant GO terms were removed using semantic clustering with REVIGO. GO terms that are enriched in the MD vs. LD comparison are shown in Table 4, and a complete list of enriched GO terms can be found in Supplementary Table S2.
| Comparison | GO ID | GO Term | Unadjusted | Adjusted |
|---|---|---|---|---|
| Upregulated Relative to ND | GO:0045214 | Sarcomere organization | 1.24 × 10−9 | 9.02 × 10−6 |
| GO:0060537 | Muscle tissue development | 3.88 × 10−9 | 1.88 × 10−5 | |
| GO:0007517 | Muscle organ development | 5.52 × 10−9 | 2.01 × 10−5 | |
| GO:0042742 | Defense response to bacterium | 4.72 × 10−7 | 8.59 × 10−4 | |
| GO:0034620 | Cellular response to unfolder protein | 3.65 × 10−6 | 4.23 × 10−3 | |
| Downregulated Relative to ND | GO:0048065 | Male courtship behavior, veined wing extension | 1.07 × 10−6 | 2.60 × 10−3 |
| GO:0006032 | Chitin catabolic process | 1.33 × 10−5 | 2.15 × 10−2 | |
| GO:0048082 | Regulation of adult chitin-containing cuticle pigmentation | 1.52 × 10−5 | 2.21 × 10−2 | |
| GO:0048067 | Cuticle pigmentation | 2.43 × 10−5 | 3.08 × 10−2 | |
| GO:0000272 | Polysaccharide catabolic process | 2.54 × 10−5 | 3.08 × 10−2 |
Summary of the top five (when available) KEGG pathways involved in LD. The table shows pathways up- and downregulated relative to ND. Enriched KEGG pathways were identified with the GAGE and Pathview packages in R. Terms were sorted by the Benjamini-Hochberg adjusted p-value. Pathways differentially expressed relative to MD are shown in Table 5, and a complete list of up- and downregulated KEGG terms can be found in Supplementary Table S3.
| Comparison | KO ID | KEGG Term | Adjusted |
|---|---|---|---|
| Upregulated Relative to ND | None | ||
| Downregulated Relative to ND | ko04141 | Protein processing in endoplasmic reticulum | 4.14 × 10−2 |